Medicine and Dentistry
Infection
100%
Clinical Trial
100%
Antiinfective Agent
100%
Critical Illness
100%
Inulin
100%
Prebiotics
100%
Intensive Care Unit
44%
Antibiotic Resistance
27%
Gut
27%
Pathogen
22%
Short Chain Fatty Acid
16%
Microbiome
16%
Broad-Spectrum Antibiotic
11%
Volunteer
5%
Real-Time Polymerase Chain Reaction
5%
Prevalence
5%
Sepsis
5%
Protocol Compliance
5%
Extended Spectrum Beta Lactamase
5%
Escherichia coli
5%
Effect Size
5%
Superinfection
5%
Wound
5%
Evacuation
5%
Randomized Clinical Trial
5%
Human Study
5%
Polysaccharide
5%
Injury
5%
Plasmid
5%
Lipopolysaccharide
5%
Placebo
5%
Infection Control
5%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Inulin
100%
Clinical Trial
100%
Critical Illness
100%
Antiinfective Agent
100%
Antimicrobial Resistance
27%
Infectious Agent
22%
Intestine Flora
16%
Short Chain Fatty Acid
16%
Antibiotics
11%
Tolerability
5%
Normal Human
5%
Prevalence
5%
Polysaccharide
5%
Injury
5%
Randomized Clinical Trial
5%
Lipopolysaccharide
5%
Microbiome
5%
Placebo
5%
Superinfection
5%
Sepsis
5%
Wound
5%
Extended Spectrum Beta Lactamase
5%
Escherichia coli
5%
Human Study
5%
Anaerobe
5%